Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 4Sarcoma 3Other solid neoplasm 3Dermatologic 3Gynecologic 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1Classical hematology 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1

Interventions

Cisplatin 28Irinotecan 18Gemcitabine 18Paclitaxel 14alvocidib 13Fluorouracil 11Oxaliplatin 10Cyclophosphamide 10Carboplatin 10Leucovorin 8Bortezomib 8Biopsy 8Taxes 7Radiotherapy 7Pemetrexed 7Magnetic Resonance Spectroscopy 7Doxorubicin 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Specimen Handling 6tanespimycin 5Vorinostat 5LMB-100 5Early Intervention, Educational 5Bevacizumab 5temsirolimus 4sargramostim 4Sorafenib 4Sirolimus 4Platinum 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Semaxinib × Other solid neoplasm × Clear all
NCT00005996 2013-12-19

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Unknown
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006014 2013-06-03

SU5416 in Treating Patients With Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00006000 2013-01-31

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡